Flyte Aviation, Inc. (VJET) stock
VJETNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 10/3086% below fair value
$0.49−0.03 (-6.13%)
Close on Nov 13, 2026Market cap $7.09MP/E –Yield –
Flyte Aviation r&d expenses
Research and development expenses are spending on new products and technology.
Flyte Aviation's R&D Expenses for the twelve months ending Jun 30, 2026 was $895.00K, up 117.2% year over year. For fiscal 2025 it was $862.00K, up 216.9% from the year before. The highest annual figure on record is $12.25M in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $862.00K | +216.9% |
| FY2024 | Dec 31, 2024 | $272.00K | -42.7% |
| FY2023 | Dec 31, 2023 | $475.00K | -92.6% |
| FY2022 | Dec 31, 2022 | $6.39M | -47.8% |
| FY2021 | Dec 31, 2021 | $12.25M | +36.8% |
| FY2020 | Dec 31, 2020 | $8.96M | +97.7% |
| FY2019 | Dec 31, 2019 | $4.53M | +63.2% |
| FY2018 | Dec 31, 2018 | $2.78M | -38.6% |
| FY2017 | Dec 31, 2017 | $4.52M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $142.00K | -8.4% |
| Q1 FY2026 | Mar 31, 2026 | $149.00K | +44.7% |
| Q4 FY2025 | Dec 31, 2025 | $328.00K | +260.4% |
| Q3 FY2025 | Sep 30, 2025 | $276.00K | +338.1% |
| Q2 FY2025 | Jun 30, 2025 | $155.00K | +91.4% |
| Q1 FY2025 | Mar 31, 2025 | $103.00K | +178.4% |
| Q4 FY2024 | Dec 31, 2024 | $91.00K | -18.8% |
| Q3 FY2024 | Sep 30, 2024 | $63.00K | -53.0% |
| Q2 FY2024 | Jun 30, 2024 | $81.00K | -66.3% |
| Q1 FY2024 | Mar 31, 2024 | $37.00K | -76.0% |
| Q3 FY2023 | Sep 30, 2023 | $112.00K | -84.6% |
| Q2 FY2023 | Jun 30, 2023 | $134.00K | -94.4% |
| Q1 FY2023 | Mar 31, 2023 | $240.00K | -92.3% |
| Q4 FY2022 | Dec 31, 2022 | $154.00K | -95.9% |
| Q3 FY2022 | Sep 30, 2022 | $727.00K | -75.3% |
| Q2 FY2022 | Jun 30, 2022 | $2.40M | -15.3% |
| Q1 FY2022 | Mar 31, 2022 | $3.12M | +13.3% |
| Q4 FY2021 | Dec 31, 2021 | $3.73M | +9.1% |
| Q3 FY2021 | Sep 30, 2021 | $2.94M | +27.2% |
| Q2 FY2021 | Jun 30, 2021 | $2.83M | +44.9% |
| Q1 FY2021 | Mar 31, 2021 | $2.75M | +112.4% |
| Q4 FY2020 | Dec 31, 2020 | $3.42M | +308.2% |
| Q3 FY2020 | Sep 30, 2020 | $2.31M | +95.6% |
| Q2 FY2020 | Jun 30, 2020 | $1.95M | +99.5% |
| Q1 FY2020 | Mar 31, 2020 | $1.30M | -15.4% |
| Q4 FY2019 | Dec 31, 2019 | $838.00K | -32.6% |
| Q3 FY2019 | Sep 30, 2019 | $1.18M | +427.7% |
| Q2 FY2019 | Jun 30, 2019 | $979.00K | -4.2% |
| Q1 FY2019 | Mar 31, 2019 | $1.53M | +435.3% |
| Q4 FY2018 | Dec 31, 2018 | $1.24M | +246.5% |
| Q3 FY2018 | Sep 30, 2018 | $224.00K | -45.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.02M | – |
| Q1 FY2018 | Mar 31, 2018 | $286.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $359.00K | – |
| Q3 FY2017 | Sep 30, 2017 | $413.00K | – |
See a number that looks wrong?